文献速递甲状腺疾病

妊娠期甲状腺功能异常的危险因素:个体参与者数据Meta分析

Risk Factors for Thyroid Dysfunction in Pregnancy: An Individual Participant Data Meta-Analysis.
PubMed 文献 · Thyroid · 2024-03-28

该个体参与者数据Meta分析纳入25个前瞻性队列共65,559名孕妇,评估现行指南推荐的危险因素对妊娠期甲状腺功能异常的预测能力。结果显示这些危险因素预测能力差,受试者工作特征曲线下面积仅0.58至0.63;甲状腺过氧化物酶抗体/甲状腺球蛋白抗体阳性与甲状腺功能异常风险升高相关,双胎妊娠与临床甲状腺功能亢进症风险升高相关。

要点

  • 现行指南推荐的年龄>30岁、产次≥2、BMI≥40等危险因素筛查率为58%,临床及亚临床甲状腺功能减退症检出率为59%。
  • 年龄、BMI和产次在全部范围内变化时,临床或亚临床甲状腺功能减退症的绝对风险变化<2%。
  • 甲状腺过氧化物酶抗体/甲状腺球蛋白抗体阳性与甲状腺功能异常风险升高相关,双胎妊娠与临床甲状腺功能亢进症风险升高相关。

核心结论

  • 本研究评估的危险因素对妊娠期甲状腺功能检测异常的预测能力差,对其用于针对性筛查的临床可用性提出疑问。
  • 甲状腺过氧化物酶抗体阳性(作为基准)是(亚临床)甲状腺功能减退症的相关危险因素。

研究设计与样本

  • 个体参与者数据Meta分析,纳入25个前瞻性队列,共65,559名孕妇。
  • 纳入标准为有妊娠期母体甲状腺功能及潜在危险因素数据的前瞻性队列研究。
  • 排除标准为既往甲状腺疾病和使用甲状腺干扰药物。
  • 采用混合效应回归模型分析个体参与者数据。

主要发现

  • 使用现行推荐危险因素(年龄>30岁、产次≥2、BMI≥40)的队列筛查率为58%,临床及亚临床甲状腺功能减退症检出率为59%。
  • 年龄和BMI在全部范围内以及任何产次下,临床或亚临床甲状腺功能减退症的绝对风险变化<2%。
  • 以母体年龄、BMI、吸烟状态、产次和采血时孕周为解释变量的受试者工作特征曲线,主要结局的曲线下面积为0.58至0.63。
  • 甲状腺过氧化物酶抗体/甲状腺球蛋白抗体阳性与临床甲状腺功能减退症相关:抗体阴性风险约0.1%,单纯甲状腺球蛋白抗体阳性2.4%,单纯甲状腺过氧化物酶抗体阳性3.8%,联合抗体阳性7.0%(p<0.001)。
  • 甲状腺过氧化物酶抗体/甲状腺球蛋白抗体阳性与亚临床甲状腺功能减退症相关:抗体阴性风险2.2%,单纯甲状腺球蛋白抗体阳性8.1%,单纯甲状腺过氧化物酶抗体阳性14.2%,联合抗体阳性20.0%(p<0.001)。

关键数值与推荐

  • 现行指南推荐的危险因素包括年龄>30岁、产次≥2、BMI≥40。
  • 治疗指征定义为临床甲状腺功能减退症、促甲状腺素>10 mU/L的亚临床甲状腺功能减退症,或甲状腺过氧化物酶抗体阳性的亚临床甲状腺功能减退症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: International guidelines recommend targeted screening to identify gestational thyroid dysfunction. However, currently used risk factors have questionable discriminative ability. We quantified the risk for thyroid function test abnormalities for a subset of risk factors currently used in international guidelines. Methods: We included prospective cohort studies with data on gestational maternal thyroid function and potential risk factors (maternal age, body mass index [BMI], parity, smoking status, pregnancy through in vitro fertilization, twin pregnancy, gestational age, maternal education, and thyroid peroxidase antibody [TPOAb] or thyroglobulin antibody [TgAb] positivity). Exclusion criteria were pre-existing thyroid disease and use of thyroid interfering medication. We analyzed individual participant data using mixed-effects regression models. Primary outcomes were overt and subclinical hypothyroidism and a treatment indication (defined as overt hypothyroidism, subclinical hypothyroidism with thyrotropin >10 mU/L, or subclinical hypothyroidism with TPOAb positivity). Results: The study population comprised 65,559 participants in 25 cohorts. The screening rate in cohorts using risk factors currently recommended (age >30 years, parity ≥2, BMI ≥40) was 58%, with a detection rate for overt and subclinical hypothyroidism of 59%. The absolute risk for overt or subclinical hypothyroidism varied <2% over the full range of age and BMI and for any parity. Receiver operating characteristic curves, fitted using maternal age, BMI, smoking status, parity, and gestational age at blood sampling as explanatory variables, yielded areas under the curve ranging from 0.58 to 0.63 for the primary outcomes. TPOAbs/TgAbs positivity was associated with overt hypothyroidism (approximate risk for antibody negativity 0.1%, isolated TgAb positivity 2.4%, isolated TPOAb positivity 3.8%, combined antibody positivity 7.0%; p < 0.001), subclinical hypothyroidism (risk for antibody negativity 2.2%, isolated TgAb positivity 8.1%, isolated TPOAb positivity 14.2%, combined antibody positivity 20.0%; p < 0.001) and a treatment indication (risk for antibody negativity 0.2%, isolated TgAb positivity 2.2%, isolated TPOAb positivity 3.0%, and combined antibody positivity 5.1%; p < 0.001). Twin pregnancy was associated with a higher risk of overt hyperthyroidism (5.6% vs. 0.7%; p < 0.001). Conclusions: The risk factors assessed in this study had poor predictive ability for detecting thyroid function test abnormalities, questioning their clinical usability for targeted screening. As expected, TPOAb positivity (used as a benchmark) was a relevant risk factor for (subclinical) hypothyroidism. These results provide insights into different risk factors for gestational thyroid dysfunction.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Osinga JAJ, Liu Y, Männistö T, et al. Risk Factors for Thyroid Dysfunction in Pregnancy: An Individual Participant Data Meta-Analysis. Thyroid. 2024. PMID: 38546971. doi:10.1089/thy.2023.0646

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。